Showing 1,281 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

First Single-Tablet PI Regimen With Darunavir and TAF at 48 Weeks

Editor's pick
NATAP
16 September 2014
New & experimental HIV treatments

Long acting HIV drugs to be developed

Editor's pick
University of Liverpool press release
15 September 2014
New & experimental HIV treatments

New medicines in development give hope to patients with HIV/AIDS

Editor's pick
Pharmaceutical Research and Manufacturers of America
11 September 2014
New & experimental HIV treatments

New HIV Drug, BMS-986001, Safe and Effective in Treatment-Naive Patients

Editor's pick
The Body
10 September 2014
New & experimental HIV treatments

Drug-level study shows feasibility of long-acting integrase inhibitor cabotegravir

Editor's pick
HIVand hepatitis.com
10 September 2014
Side effects

New Tenofovir Alafenamide Combo Pill Has Less Effect on Kidneys and Bones

Editor's pick
HIVandhepatitis.com
9 September 2014
New & experimental HIV treatments

EU marketing authorization for ViiV Healthcare HIV drug Triumeq

Editor's pick
Pharma Letter
4 September 2014
New & experimental HIV treatments

The Role of Triumeq in HIV Treatment

Editor's pick
The Body
4 September 2014
New & experimental HIV treatments

Aiming For HIV's Weak Spot - The new generation of gp120 entry inhibitors

Editor's pick
C&EN - Chemical and Engineering News
2 September 2014
New & experimental HIV treatments

FDA Approves New Single-Tablet HIV Regimen, Triumeq

Editor's pick
Aidsmeds.com
26 August 2014
The search for a cure

Protein tethers HIV and Ebola to cells

Editor's pick
Futurity
26 August 2014
New & experimental HIV treatments

Theraclone Sciences cuts HIV antibodies deal with Gilead

Editor's pick
San Francisco Business Times (blog)
31 July 2014
New & experimental HIV treatments

The Medicines Patent Pool (MPP) broadens collaboration with Gilead Sciences: Signs licence for Phase III medicine tenofovir alafenamide (TAF)

Editor's pick
Medicines Patent Pool
25 July 2014
The search for a cure

Novel techniques probed in cure research

News
22 July 2014
Hepatitis C treatment

HIV, HCV and TB Pipeline Report

Editor's pick
Treatment Action Group & i-Base
21 July 2014
New & experimental HIV treatments

Therapy with newer, safer antiretrovirals an option for the majority of HIV-positive patients

News
11 July 2014
New & experimental HIV treatments

Triumeq® (dolutegravir/abacavir/lamivudine) single-tablet regimen receives positive CHMP opinion in Europe for the treatment of HIV

Editor's pick
Viiv Healthcare press release
30 June 2014
Treatment guidelines

Dolutegravir in HIV-1 infection: Added benefit in adult patients

Editor's pick
Science Daily
19 June 2014
New & experimental HIV treatments

Glaxo's ViiV Joins J&J's Janssen to Develop Single-Pill HIV Drug

Editor's pick
Bloomberg
13 June 2014
How HIV works

Paper explores new theory on spread of HIV by "popular" cells

Editor's pick
HIV / AIDS News From Medical News Today
11 June 2014
New & experimental HIV treatments

First Patient Enrolled in New Phase 3 Trial Program Investigating a Once-Daily formulation of raltegravir (Isentress)

Editor's pick
Merck
6 June 2014
New & experimental HIV treatments

Dolutegravir in HIV-1 infection: added benefit in adult patients

Editor's pick
IQWIG
23 May 2014
New & experimental HIV treatments

Investigational protease inhibitor TMC310911 highly potent in phase 2 study

News
4 May 2014
Pharmaceutical industry

Gilead Sciences’ New Drug Applications for Cobicistat and Elvitegravir for HIV Therapy Accepted by U.S. FDA

Editor's pick
Gilead press release
22 April 2014